MCViewPoint

Opinion from a Libertarian ViewPoint

Posts Tagged ‘Johnson & Johnson’

A Legacy of Corruption in the FDA and Big Pharma | Mises Wire

Posted by M. C. on September 14, 2021

  • Moderna has never developed an approved drug, yet one of their board members was placed in charge of Operation Warp Speed. This certainly is unrelated to the fact that they received the most federal vaccine research and development funding and have received over $6 billion from our government since the start of the pandemic.
  • https://mises.org/wire/legacy-corruption-fda-and-big-pharma

    Liam Cosgrove

    Our healthcare system is broken, a fact nobody would have disputed in precovid days. Regulatory capture is a reality, and the pharmaceutical industry is fraught with examples. Yet we trusted private-public partnerships to find an optimal solution to a global pandemic, assuming a crisis would bring out the best in historically corrupt institutions.

    Here is a brief list of less-than-savory behavior demonstrated by our titans of healthcare: 

    • Pfizer and Johnson & Johnson plead guilty to “misbranding with the intent to defraud or mislead” and paying “kickbacks to health care providers to induce them to prescribe [their] drugs,” resulting in fines of $2.3 billion in 2009 and $2.2 billion in 2013, respectively. 
    • Pfizer settled another lawsuit for “manipulating studies” and “suppressing negative findings” just a few years later. 
    • Moderna has never developed an approved drug, yet one of their board members was placed in charge of Operation Warp Speed. This certainly is unrelated to the fact that they received the most federal vaccine research and development funding and have received over $6 billion from our government since the start of the pandemic.
    • Gilead Sciences paid $97 million in fines, because it “illegally used a non-profit foundation as a conduit to pay the Medicare co-pays for its own drug.”
    • In 2005, AstraZeneca’s drug Crestor was shown to be linked to a life-threatening muscle disease while the company withheld evidence of this and two dozen other effects from the public.
    • In 2012, GlaxoSmithKline paid $3 billion in fines, as it “failed to include certain safety data” relating to their drug, since labeled as connected to heart failure and attacks.

    Thankfully, our public health guardians are in place to protect us from the greed and deceit of the private sector, right? Wrong. Enjoy another brief list:

    • The Food and Drug Administration (FDA) worked behind the scenes with company Biogen to alter previously conducted trials of their $56,000 per year Alzheimer’s treatment, and “by removing the subset of people for whom the drug didn’t work, they found a slight statistical effect in favor of the drug.” Even after doing this, an advisory committee voted 10–0 against approving the drug. The FDA approved the drug anyway, causing three committee members to resign.
    • In that case, the third-party advisors did the right thing. This is not always the case: a study by Science Magazine tracking 107 FDA advisors for four years found that 62 percent received money from related drug makers, with 25 percent receiving over $100,000 and 6 percent receiving over $1 million. It only takes a few corrupt advisors to fix a panel and feign medical consensus.
    • In 2017, it was revealed that the acting Centers for Disease Control and Prevention (CDC) director for heart disease and stroke prevention had been secretly communicating with Coca-Cola, providing guidance on how “to influence world health authorities on sugar and beverage policy matters.”

    The American healthcare system remains mired in good old-fashioned crony capitalism, fascism, corporatism, mercantilism, protectionism … fancy words for when private companies work with governments to subvert the forces of competition. The suppression of research into off-patent drugs is a nasty symptom of this problem.

    While there are countless drugs to which this applies, we will discuss ivermectin. First, addressing the drug’s dismissal by its own manufacturer, Merck, let it be known that ivermectin is no longer under patent. Merck no longer owns exclusive rights to the drug’s production. The forces of competition have been bestowed upon the drug, thus making it far cheaper. Meanwhile, Merck is also currently rolling out an oral covid treatment, which the US government is providing $1.2 billion in funding to research. This would be under patent and may explain the company’s opposition to using ivermectin.

    The usefulness of ivermectin remains debatable. However, it’s important to note that in early April 2020,  a study at the University of Monash in Australia suggested it can be effective. Moreover, the drug is FDA approved, has existed for forty years, won a Nobel Prize, and is extremely safe when used at recommended levels. Given the crisis and ivermectin’s safety—safe even if not conferring big benefits for covid sufferers—the rush to condemn use of the drug appears suspect. Indeed, a week after the Australian study was published, the FDA advised against using ivermectin for COVID-19 treatment, forcing desperate people to the black market and to self-prescribe versions of the drug intended for animals.

    The FDA noted subsequently that “additional testing is needed.” Yet, to date, there has not been a single completed government-funded study on the effectiveness of ivermectin against covid-19. Meanwhile, they have funneled billions toward research into vaccines and patented treatments. The National Institutes of Health (NIH) funded trials for remdesivir, still under patent with Gilead, despite it being less effective and having more severe side effects than ivermectin. The FDA approved remdesivir under emergency use authorization (EUA) despite published trials, later stating “remdesivir was not associated with statistically significant clinical benefits.”

    One would think that if “additional testing” is so important, the US government might be interested in funding research to examine the potential benefits of cheap, safe, and proven drugs that have shown some promise in treating covid. But that’s clearly not what going on. Funding is geared toward helping huge pharmaceutical companies develop new patented drugs. As long Big Pharma wants it, and if there’s a profit to be made, apparently our government will be there to provide funding. Author:

    Liam Cosgrove

    Be seeing you

    Posted in Uncategorized | Tagged: , , , , | 2 Comments »

    Covid Hysteria and the Groomers of the Virus Patrol – LewRockwell

    Posted by M. C. on June 12, 2020

    And, yes, here’s the list of the top five firms being supported by billions from Washington in the race for a Covid vaccine, which may or may not happen, but whether safe or not will be of no never-mind to Big Pharma.

    After all, Washington has already indemnified them against lawsuits; pretty much guaranteed that they can name their charge per dose; and will be doing all it can to make getting a tap on the arm from one or more of the Big Pharma competitors a mandatory duty of citizenship.

    https://www.lewrockwell.com/2020/06/david-stockman/covid-hysteria-and-the-groomers-of-the-virus-patrol/

    By

    David Stockman’s Contra Corner

    Dr. Fauci and the Scarf Lady are not the only Virus Patrol miscreants spreading the Covid Hysteria and thereby empowering the authorities to keep suffocating everyday economic life and personal liberty in America.

    In fact, there is a whole camarilla of current and former health officials, purported disease experts, all-purpose talking heads and other Washington apparatchiks who continue to appear on mainstream media, peddling the hoary tale that coronavirus is some kind of horror flick monster: It purportedly just keeps springing from its Lockdown grave – whack-a-mole fashion – the instant officialdom relaxes its quarantine edicts.

    Call these people the “groomers” of Big Pharma, and their job is to keep public fears on the boil so that the demand for high-priced treatments, cures and preventative vaccines becomes overwhelming. And given that the Covid is now rapidly succumbing to the exhaustion of its infection cycle and the summertime sun, their exact current mission is one of bridging the gap.

    That is, finding and publicizing local outbreaks and “hot spots” during the months just ahead so that the Virus Patrol will remain in full control of policy and the narrative until the Covid makes its forecasted second wave rebound during next fall’s flu season.

    After all, they desperately need these hot spots to keep the aggregate narrative alive because it is visibly collapsing by the day.

    Back in early May, for instance, the NYT breathlessly carried a leaked study from the Trump Administration that projected a massive surge of new infections and a near doubling of daily death rates by early June relative to levels than extant:

    As President Trump presses for states to reopen their economies, his administration is privately projecting a steady rise in the number of coronavirus cases and deaths over the next several weeks. The daily death toll will reach about 3,000 on June 1, according to an internal document obtained by The New York Times, a 70 percent increase from the current number of about 1,750.

    The projections, based on government modeling pulled together by the Federal Emergency Management Agency, forecast about 200,000 new cases each day by the end of the month, up from about 25,000 cases a day currently.

    The numbers underscore a sobering reality: The United States has been hunkered down for the past seven weeks to try slowing the spread of the virus, but reopening the economy will make matters worse.

    Needless to say, that one went down the memory hole ages ago (i.e. around Memorial Day). As of June 10, in fact, actual daily averages for the month to date were:

    • 827 deaths per day, representing a 53% decline, not a 70% increase;
    • 20,694 new cases per day, representing a 17% decline, not an 8X increase;

    In other words, these Washington modelers (this one was prepared by FEMA) couldn’t hit the broadside of a barn with the antiaircraft guns Chairman Kim uses to dispatch his adversaries. So to keep the Covid-Hysteria alive, they send out the hot spot “groomers”.

    On of the most mendacious of these groomers is Dr. Scott Gottlieb, who was the Donald’s first FDA commissioner and is an alleged pedigreed “conservative” with a berth at the American Enterprise Institute to burnish his numerous sinecures with Big Pharma.

    Gottlieb is also a CNBC regular, and yesterday, sitting astride a screen crawler which read “Texas reports second day of record hospitalizations”, he was busy promulgating the “hot spot” news about two red states, whose merely semi-craven GOP governors have belatedly attempted to get their economies back in business:

    When you look at hotspot regions like Arizona and Texas, they have to be concerned, particularly areas around Houston right now. They could lose control of this very quickly,” says @ScottGottliebMD on balancing re-opening with public health.

    We call bullshit!

    Gottlieb was peddling a pimple on the elephant’s ass because, apparently, cable TV audiences generally and bubble vision’s especially, were born yesterday. That is, they are infantile victims of recency and confirmation biases and will apparently believe anything served up in a context-free modality. Read the rest of this entry »

    Posted in Uncategorized | Tagged: , , , , , , , , , | Leave a Comment »